Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy A Bates

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Biorxiv : the Preprint Server for Biology|June 19, 2024
A Nanobody Interaction with SARS-CoV-2 Spike Allows the Versatile Targeting of Lentivirus VectorsAyna Alfadhli, Timothy A Bates, Robin Lid Barklis, et al.
Journal of Virology|August 29, 2024
A nanobody interaction with SARS-COV-2 Spike allows the versatile targeting of lentivirus vectorsAyna Alfadhli, Timothy A Bates, Robin Lid Barklis, et al.
Biosensors|February 26, 2026
A Nanobody-Based Lateral Flow Assay for Point-of-Care DiagnosticsTimothy A Bates, Sintayehu K Gurmessa, Jules B Reyes-Weinstein, et al.
Medrxiv : the Preprint Server for Health Sciences|April 8, 2024
Humoral Immunity Elicited by the XBB.1.5 Monovalent COVID-19 VaccineXammy Huu Nguyenla, Timothy A Bates, Mila Trank-Greene, et al.
Emerging Infectious Diseases|April 26, 2024
Evaluating Humoral Immunity Elicited by XBB.1.5 Monovalent COVID-19 VaccineXammy Huu Nguyenla, Timothy A Bates, Mila Trank-Greene, et al.
Iscience|February 28, 2022
A potent alpaca-derived nanobody that neutralizes SARS-CoV-2 variantsJules B Weinstein, Timothy A Bates, Hans C Leier, et al.
Cell Reports|February 5, 2021
Cross-reactivity of SARS-CoV structural protein antibodies against SARS-CoV-2Timothy A Bates, Jules B Weinstein, Scotland Farley, et al.
Virology|July 10, 2021
Capsid-specific nanobody effects on HIV-1 assembly and infectivityAyna Alfadhli, CeAnn Romanaggi, Robin Lid Barklis, et al.
JAMA|December 16, 2021
Antibody Response and Variant Cross-Neutralization After SARS-CoV-2 Breakthrough InfectionTimothy A Bates, Savannah K McBride, Bradie Winders, et al.
Biorxiv : the Preprint Server for Biology|August 9, 2020
Cross-reactivity of SARS-CoV structural protein antibodies against SARS-CoV-2Timothy A Bates, Jules B Weinstein, Scotland E Farley, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Biorxiv : the Preprint Server for Biology|June 19, 2024
A Nanobody Interaction with SARS-CoV-2 Spike Allows the Versatile Targeting of Lentivirus VectorsAyna Alfadhli, Timothy A Bates, Robin Lid Barklis, et al.
Journal of Virology|August 29, 2024
A nanobody interaction with SARS-COV-2 Spike allows the versatile targeting of lentivirus vectorsAyna Alfadhli, Timothy A Bates, Robin Lid Barklis, et al.
Biosensors|February 26, 2026
A Nanobody-Based Lateral Flow Assay for Point-of-Care DiagnosticsTimothy A Bates, Sintayehu K Gurmessa, Jules B Reyes-Weinstein, et al.
Medrxiv : the Preprint Server for Health Sciences|April 8, 2024
Humoral Immunity Elicited by the XBB.1.5 Monovalent COVID-19 VaccineXammy Huu Nguyenla, Timothy A Bates, Mila Trank-Greene, et al.
Emerging Infectious Diseases|April 26, 2024
Evaluating Humoral Immunity Elicited by XBB.1.5 Monovalent COVID-19 VaccineXammy Huu Nguyenla, Timothy A Bates, Mila Trank-Greene, et al.
Iscience|February 28, 2022
A potent alpaca-derived nanobody that neutralizes SARS-CoV-2 variantsJules B Weinstein, Timothy A Bates, Hans C Leier, et al.
Cell Reports|February 5, 2021
Cross-reactivity of SARS-CoV structural protein antibodies against SARS-CoV-2Timothy A Bates, Jules B Weinstein, Scotland Farley, et al.
Virology|July 10, 2021
Capsid-specific nanobody effects on HIV-1 assembly and infectivityAyna Alfadhli, CeAnn Romanaggi, Robin Lid Barklis, et al.
JAMA|December 16, 2021
Antibody Response and Variant Cross-Neutralization After SARS-CoV-2 Breakthrough InfectionTimothy A Bates, Savannah K McBride, Bradie Winders, et al.
Biorxiv : the Preprint Server for Biology|August 9, 2020
Cross-reactivity of SARS-CoV structural protein antibodies against SARS-CoV-2Timothy A Bates, Jules B Weinstein, Scotland E Farley, et al.
Pageof 4